Becker Annette
Med Monatsschr Pharm. 2017 Jun;40(6):255-60.
In the last ten years opioid prescription has increased considerably. It is not that cancer patients would receive more analgesics, but it rather can be traced to a rising use of opioids for non cancer chronic pain (NCCP). There is evidence that serious opioid overuse may be present. Why should NCCP patients not benefit from opioid therapy and which side effects would justify to deprive NCCP patients of these strong analgesics? Our article summarizes the current discussion on opioid use in NCCP and outlines current evidence.
在过去十年中，阿片类药物的处方量大幅增加。并非癌症患者会获得更多的镇痛药，而是可以追溯到阿片类药物在非癌性慢性疼痛（NCCP）治疗中的使用增加。有证据表明可能存在严重的阿片类药物过度使用情况。为什么NCCP患者不能从阿片类药物治疗中获益，以及哪些副作用会导致剥夺NCCP患者使用这些强效镇痛药的权利？我们的文章总结了当前关于NCCP中阿片类药物使用的讨论，并概述了当前的证据。
